Startups
Asgard Therapeutics
https://asgardthx.comDeveloper of vivo direct cell reprogramming for cancer immunotherapy.
Summary
Industry
Total funding Amount
$37M
Fundraising History
-
Mar 14 '24 Series A$30M
-
Nov 01 '21 Seed$6.9M
Investors
-
Series A
-
Series A
-
Series A
-
Seed